
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
LLY | NYSE | USD | Real-time | |
0Q1G | London | CHF | Real-time | |
LLY | Mexico | MXN | Delayed | |
LLY | Switzerland | CHF | Delayed | |
LLY | TradeGate | EUR | Delayed | |
LLY | Frankfurt | EUR | Delayed | |
LLY | Xetra | EUR | Delayed | |
LILY34 | BM&FBovespa | BRL | Delayed |
Eli Lilly and Company is engaged in drug manufacturing businesses. The Company discovers, develops, manufactures, and markets products in the human pharmaceutical products segment. Its diabetes products include Basaglar, Humalog, Humulin, Jardiance, Mounjaro, and Trulicity. Its oncology products consist of Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. Its immunology products include Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, and Zyprexa. Its other therapies consist of Bamlanivimab and etesevimab, Bebtelovimab, Cialis, and Forteo. It maintains special business groups for service wholesalers, pharmacy benefit managers, managed care organizations, group purchasing organizations, government and long-term care institutions, hospitals, and certain retail pharmacies. It manufactures and distributes its products through facilities in the United States, including Puerto Rico, and other countries. Its products are sold in over 110 countries.
Name | Age | Since | Title |
---|---|---|---|
Sidney Taurel | 72 | 1991 | Chairman Emeritus |
David A. Ricks | 53 | 2012 | Chairman, CEO & President |
Carolyn R. Bertozzi | 54 | 2017 | Independent Director |
William G. Kaelin | 64 | 2012 | Independent Director |
Marschall S. Runge | 68 | 2013 | Independent Director |
Ralph Alvarez | 67 | 2009 | Independent Director |
Katherine Baicker | 50 | 2011 | Independent Director |
J. Erik Fyrwald | 63 | 2005 | Independent Director |
Jamere Jackson | 54 | 2016 | Independent Director |
Juan Ricardo Luciano | 62 | 2016 | Lead Independent Director |
Karen M. Walker | 61 | 2018 | Independent Director |
Kimberly H. Johnson | 50 | 2021 | Independent Director |
Mary Lynne Hedley | 60 | 2022 | Independent Director |
Gabrielle E. Greene-Sulzberger | 63 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review